Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

AI Breakthroughs, Backlash & Bold Moves: Global AI News Roundup (Aug 16–17, 2025)

AI Breakthroughs, Backlash & Bold Moves: Global AI News Roundup (Aug 16–17, 2025)

OpenAI released GPT-5 and rolled it out to all 700 million ChatGPT users, with Sam Altman describing it as the first mainline model that feels like a PhD‑level expert and capable of generating full working software on demand. China’s Pan
Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Wegovy (semaglutide) received FDA accelerated approval to treat metabolic dysfunction-associated steatohepatitis (MASH), becoming the first GLP-1 therapy cleared for MASH in a patient population estimated at about 5% of U.S. adults, based on part 1 of an ongoing trial showing
1 180 181 182 183 184 220
Go toTop